Regulations.gov document
Final Decision on Withdrawal of PEPAXTO (melphalan flufenamide) Following Appeal of the…
Notice · FDA-2023-N-3167 · posted Apr 18, 2024
Key facts
| Document ID | FDA-2023-N-3167-0050 |
|---|---|
| Title | Final Decision on Withdrawal of PEPAXTO (melphalan flufenamide) Following Appeal of the Proposal To Withdraw Approval; Availability of Final Decision |
| Document type | Notice |
| Subtype | Withdrawal |
| Agency | FDA |
| Docket | FDA-2023-N-3167 |
| Posted | Apr 18, 2024 |
| Federal Register citation | 89 FR 27766 |
| FR document number | 2024-08274 |
| Comment period opens | Apr 18, 2024 |
| Effective date | Apr 18, 2024 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: